What is the current valuation of the Pharmaceutical Granulation Equipment Market?

As of 2024, the market valuation was 5.67 USD Billion. Read More

What is the projected market size for the Pharmaceutical Granulation Equipment Market by 2035?

The market is expected to reach 8.19 USD Billion by 2035. Read More

What is the expected CAGR for the Pharmaceutical Granulation Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 3.4%. Read More

Which equipment types are leading in the Pharmaceutical Granulation Equipment Market?

High Shear Granulators and Fluid Bed Granulators are among the leading equipment types, with valuations of 2.4 and 1.7 USD Billion respectively by 2035. Read More

How does the market segment by formulation type appear in terms of valuation?

By 2035, Solid Dosage is projected to reach 4.0 USD Billion, indicating its dominance in the formulation type segment. Read More

What are the key end-use segments in the Pharmaceutical Granulation Equipment Market?

Pharmaceutical Manufacturers lead the end-use segment, with a projected valuation of 4.8 USD Billion by 2035. Read More

What scale of operation is expected to dominate the market?

The Industrial Scale is anticipated to dominate, with a projected valuation of 5.29 USD Billion by 2035. Read More

Who are the key players in the Pharmaceutical Granulation Equipment Market?

Key players include GEA Group AG, Fette Compacting GmbH, and Bosch Packaging Technology, among others. Read More

What is the projected growth for Roller Compactors in the market?

Roller Compactors are expected to grow to 1.4 USD Billion by 2035. Read More

How does the market for Contract Manufacturing Organizations appear in terms of growth?

The market for Contract Manufacturing Organizations is projected to reach 2.4 USD Billion by 2035, indicating substantial growth. Read More

Pharmaceutical Granulation Equipment Market

ID: MRFR/MED/41605-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Pharmaceutical Granulation Equipment Market Research Report By Equipment Type (High Shear Granulator, Fluid Bed Granulator, Roller Compactor, Granulation and Coating Equipment), By Formulation Type (Solid Dosage, Liquid Dosage, Semi-Solid Dosage), By End Use (Pharmaceutical Manufacturers, Contract Manufacturing Organizations, Research Institutions), By Scale of Operation (Laboratory Scale, Pilot Scale, Industrial Scale) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Pharmaceutical Granulation Equipment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)3.4%

2024 Market Size$ 5.67 Billion

2025 Market Size$ 5.86 Billion

2035 Market Size$ 8.19 Billion

Key Players

GEA Group AG

Fette Compacting GmbH

Bosch Packaging Technology

Schneider Electric

Korsch AG

Romaco Pharmatechnik GmbH

Trends

Technological Advancements
Focus on Quality and Compliance
Sustainability Initiatives

Opportunities

Increasing Investment in Pharmaceutical R&D
Regulatory Compliance and Quality Assurance
Rising Demand for Advanced Drug Formulations

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Equipment Type (USD Billion)
  1. 4.1.1 High Shear Granulator
  2. 4.1.2 Fluid Bed Granulator
  3. 4.1.3 Roller Compactor
  4. 4.1.4 Granulation and Coating Equipment
2. 4.2 Healthcare, BY Formulation Type (USD Billion)
  1. 4.2.1 Solid Dosage
  2. 4.2.2 Liquid Dosage
  3. 4.2.3 Semi-Solid Dosage
3. 4.3 Healthcare, BY End Use (USD Billion)
  1. 4.3.1 Pharmaceutical Manufacturers
  2. 4.3.2 Contract Manufacturing Organizations
  3. 4.3.3 Research Institutions
4. 4.4 Healthcare, BY Scale of Operation (USD Billion)
  1. 4.4.1 Laboratory Scale
  2. 4.4.2 Pilot Scale
  3. 4.4.3 Industrial Scale
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 GEA Group AG (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Fette Compacting GmbH (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bosch Packaging Technology (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Schneider Electric (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Korsch AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Romaco Pharmatechnik GmbH (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 L.B. Bohle Maschinen + Verfahren GmbH (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Coperion GmbH (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY EQUIPMENT TYPE
4. 6.4 US MARKET ANALYSIS BY FORMULATION TYPE
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 US MARKET ANALYSIS BY SCALE OF OPERATION
7. 6.7 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
8. 6.8 CANADA MARKET ANALYSIS BY FORMULATION TYPE
9. 6.9 CANADA MARKET ANALYSIS BY END USE
10. 6.10 CANADA MARKET ANALYSIS BY SCALE OF OPERATION
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
14. 6.14 GERMANY MARKET ANALYSIS BY END USE
15. 6.15 GERMANY MARKET ANALYSIS BY SCALE OF OPERATION
16. 6.16 UK MARKET ANALYSIS BY EQUIPMENT TYPE
17. 6.17 UK MARKET ANALYSIS BY FORMULATION TYPE
18. 6.18 UK MARKET ANALYSIS BY END USE
19. 6.19 UK MARKET ANALYSIS BY SCALE OF OPERATION
20. 6.20 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
22. 6.22 FRANCE MARKET ANALYSIS BY END USE
23. 6.23 FRANCE MARKET ANALYSIS BY SCALE OF OPERATION
24. 6.24 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
26. 6.26 RUSSIA MARKET ANALYSIS BY END USE
27. 6.27 RUSSIA MARKET ANALYSIS BY SCALE OF OPERATION
28. 6.28 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
29. 6.29 ITALY MARKET ANALYSIS BY FORMULATION TYPE
30. 6.30 ITALY MARKET ANALYSIS BY END USE
31. 6.31 ITALY MARKET ANALYSIS BY SCALE OF OPERATION
32. 6.32 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
34. 6.34 SPAIN MARKET ANALYSIS BY END USE
35. 6.35 SPAIN MARKET ANALYSIS BY SCALE OF OPERATION
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USE
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY SCALE OF OPERATION
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
42. 6.42 CHINA MARKET ANALYSIS BY FORMULATION TYPE
43. 6.43 CHINA MARKET ANALYSIS BY END USE
44. 6.44 CHINA MARKET ANALYSIS BY SCALE OF OPERATION
45. 6.45 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
46. 6.46 INDIA MARKET ANALYSIS BY FORMULATION TYPE
47. 6.47 INDIA MARKET ANALYSIS BY END USE
48. 6.48 INDIA MARKET ANALYSIS BY SCALE OF OPERATION
49. 6.49 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
51. 6.51 JAPAN MARKET ANALYSIS BY END USE
52. 6.52 JAPAN MARKET ANALYSIS BY SCALE OF OPERATION
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USE
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY SCALE OF OPERATION
57. 6.57 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
59. 6.59 MALAYSIA MARKET ANALYSIS BY END USE
60. 6.60 MALAYSIA MARKET ANALYSIS BY SCALE OF OPERATION
61. 6.61 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
63. 6.63 THAILAND MARKET ANALYSIS BY END USE
64. 6.64 THAILAND MARKET ANALYSIS BY SCALE OF OPERATION
65. 6.65 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
67. 6.67 INDONESIA MARKET ANALYSIS BY END USE
68. 6.68 INDONESIA MARKET ANALYSIS BY SCALE OF OPERATION
69. 6.69 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
71. 6.71 REST OF APAC MARKET ANALYSIS BY END USE
72. 6.72 REST OF APAC MARKET ANALYSIS BY SCALE OF OPERATION
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
76. 6.76 BRAZIL MARKET ANALYSIS BY END USE
77. 6.77 BRAZIL MARKET ANALYSIS BY SCALE OF OPERATION
78. 6.78 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
80. 6.80 MEXICO MARKET ANALYSIS BY END USE
81. 6.81 MEXICO MARKET ANALYSIS BY SCALE OF OPERATION
82. 6.82 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
84. 6.84 ARGENTINA MARKET ANALYSIS BY END USE
85. 6.85 ARGENTINA MARKET ANALYSIS BY SCALE OF OPERATION
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SCALE OF OPERATION
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY SCALE OF OPERATION
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY SCALE OF OPERATION
99. 6.99 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
101. 6.101 REST OF MEA MARKET ANALYSIS BY END USE
102. 6.102 REST OF MEA MARKET ANALYSIS BY SCALE OF OPERATION
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY EQUIPMENT TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END USE, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY SCALE OF OPERATION, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY SCALE OF OPERATION, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.3.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.4.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.5.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.6.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.7.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.8.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.9.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.10.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.11.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.12.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.13.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.14.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.15.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.16.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.17.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.18.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.19.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.20.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.21.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.22.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.23.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.24.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.25.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.26.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.27.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.28.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.29.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.30.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Pharmaceutical Granulation Equipment Market Segmentation

Pharmaceutical Granulation Equipment Market By Equipment Type (USD Billion, 2025-2035)

High Shear Granulator
Fluid Bed Granulator
Roller Compactor
Granulation and Coating Equipment

Pharmaceutical Granulation Equipment Market By Formulation Type (USD Billion, 2025-2035)

Solid Dosage
Liquid Dosage
Semi-Solid Dosage

Pharmaceutical Granulation Equipment Market By End Use (USD Billion, 2025-2035)

Pharmaceutical Manufacturers
Contract Manufacturing Organizations
Research Institutions

Pharmaceutical Granulation Equipment Market By Scale of Operation (USD Billion, 2025-2035)

Laboratory Scale
Pilot Scale
Industrial Scale

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”